These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18451675)

  • 1. Cross-membrane flux is a major factor influencing dialysis patient outcomes.
    Canaud B; Chenine L; Henriet D; Leray H
    Contrib Nephrol; 2008; 161():178-184. PubMed ID: 18451675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin and beta2-microglobulin kinetics with three different dialysis modalities.
    Mandolfo S; Borlandelli S; Imbasciati E
    Int J Artif Organs; 2006 Oct; 29(10):949-55. PubMed ID: 17211816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprocessing high-flux polysulfone dialyzers does not negatively impact solute removal in short-daily online hemodiafiltration.
    Melo NC; Moyses RM; Elias RM; Castro MC
    Hemodial Int; 2014 Apr; 18(2):473-80. PubMed ID: 24393428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Performance Assessment of CorDiax Filters in Hemodialysis and Hemodiafiltration.
    Potier J; Bowry S; Canaud B
    Contrib Nephrol; 2017; 189():237-245. PubMed ID: 27951574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship.
    Ahrenholz PG; Winkler RE; Michelsen A; Lang DA; Bowry SK
    Clin Nephrol; 2004 Jul; 62(1):21-8. PubMed ID: 15267009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of large uremic toxins by a dialyzer specifically designed for high-volume convective therapies.
    Maduell F; Arias-Guillen M; Fontseré N; Ojeda R; Rico N; Vera M; Elena M; Bedini JL; Wieneke P; Campistol JM
    Blood Purif; 2014; 37(2):125-30. PubMed ID: 24662288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Middle molecules removal. Beyond beta2-microglobulin].
    Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
    Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration.
    Krieter DH; Falkenhain S; Chalabi L; Collins G; Lemke HD; Canaud B
    Kidney Int; 2005 Jan; 67(1):349-56. PubMed ID: 15610261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving beyond small solute clearance: What evidence is there for more permeable dialyzers and haemodiafiltration?
    Davenport A
    Hemodial Int; 2018 Oct; 22(S2):S24-S28. PubMed ID: 30411460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed predilution and postdilution online hemodiafiltration compared with the traditional infusion modes.
    Pedrini LA; De Cristofaro V; Pagliari B; Samà F
    Kidney Int; 2000 Nov; 58(5):2155-65. PubMed ID: 11044237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of beta-2-microglobulin and middle molecules in haemodiafiltration.
    Tattersall J
    Contrib Nephrol; 2007; 158():201-209. PubMed ID: 17684359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution and physical principles of convection-based dialysis treatment].
    David S
    G Ital Nefrol; 2012; 29 Suppl 55():S3-11. PubMed ID: 22723138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sad but forgotten truth: the story of slow-moving solutes in fast hemodialysis.
    Eloot S; Van Biesen W; Vanholder R
    Semin Dial; 2012; 25(5):505-9. PubMed ID: 22925227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can convective therapies improve dialysis outcomes?
    Locatelli F; Manzoni C; Cavalli A; Di Filippo S
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):476-80. PubMed ID: 19726986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise Quantitative Assessment of the Clinical Performances of Two High-Flux Polysulfone Hemodialyzers in Hemodialysis: Validation of a Blood-Based Simple Kinetic Model Versus Direct Dialysis Quantification.
    Lim PS; Lin Y; Chen M; Xu X; Shi Y; Bowry S; Canaud B
    Artif Organs; 2018 May; 42(5):E55-E66. PubMed ID: 29193165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Treatment Duration and Frequency on Uremic Solute Kinetics, Clearances and Concentrations.
    Leypoldt JK; Meijers BK
    Semin Dial; 2016 Nov; 29(6):463-470. PubMed ID: 27578429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On-line haemodiafiltration with sorbent-regenerated ultrafiltrate as replacement fluid: Beta2-microglobulin removal versus filtration fraction].
    Emiliani G; Briganti M; Montanari A; Isola E; Fusaroli M
    G Ital Nefrol; 2004; 21 Suppl 30():S80-4. PubMed ID: 15747312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane requirements for high-flux and convective therapies.
    Bowry SK
    Contrib Nephrol; 2011; 175():57-68. PubMed ID: 22188688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group.
    Locatelli F; Mastrangelo F; Redaelli B; Ronco C; Marcelli D; La Greca G; Orlandini G
    Kidney Int; 1996 Oct; 50(4):1293-302. PubMed ID: 8887291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.